GeneDx Holdings Corp reports results for the quarter ended in September - Earnings Summary

GeneDx Holdings

30/10/2023 21:40

* GeneDx Holdings Corp  WGS.OQ  reported a quarterly
adjusted loss
of 82 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of $1.31 per share.
    * Revenue fell 36% to $53.30 million from a year ago;
analysts
expected $52.41 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was a
loss
of $1.64​.
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * GeneDx Holdings Corp shares had fallen by 19.8% this
quarter and
lost 66.5% so far this year.
    * The company reported a quarterly loss of $42.29 million.
    * Wall Street's median 12-month price target for GeneDx
Holdings
Corp is $9.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 30 at 09:40 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -1.31          -0.82          Beat
 Jun. 30 2023      -1.31          -1.64          Missed
 Mar. 31 2023      -2.14          -2.44          Missed
 Dec. 31 2022      -5.28          -8.25          Missed